Rome Therapeutics bags $77m Series B
Rome Therapeutics, a biotechnology company, has closed $77 million in Series B financing.
Rome Therapeutics, a biotechnology company, has closed $77 million in Series B financing.
Copyright PEI Media
Not for publication, email or dissemination